Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes.

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...

Hims & Hers believes that is where the controversy lies. “We called on the industry and said that they need to change — and ...

The body does not absorb berberine well, limiting its ability to affect body weight significantly. However, berberine may ...

Hims & Hers Health is set to have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to ...

Novo Nordisk shares tumbled last year when obesity candidate CagriSema failed to clear a weight loss bar of 25%. Now, ...

This study provides valuable insight into the increasing use of obesity drugs. The rising prescription numbers suggest that ...

Online sellers of knockoff GLP-1 drugs have seized on shortages as an opportunity to advertise a more steady, lower-cost supply of the products compared to branded versions. One such company, Hims & ...

Amy Schumer opened up about taking Ozempic and losing 30 pounds. She also shared that she was “bedridden” with nausea, which is why she ultimately stopped taking the medication. “But other people take ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...